PMDIY (Pro Medicus) Marketable Securities: $69.9 Mil (As of Dec. 2025)


PMDIY Pro Medicus Ltd PMDIY
77 GF Score
Price $30.00
GF Value $39.90
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Pro Medicus Marketable Securities?

Pro Medicus PMDIY +3.45% 77 Marketable Securities is $69.9 Mil as of Dec. 2025. GuruFocus rates PMDIY with a GF Score™ of 77/100 and a GF Value™ of $39.90 (Modestly Undervalued). The stock has 1 warning sign investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Pro Medicus's Marketable Securities for the quarter that ended in Dec. 2025 was $69.9 Mil.

Pro Medicus's annual Marketable Securities increased from Jun. 2023 ($20.3 Mil) to Jun. 2024 ($20.9 Mil) and increased from Jun. 2024 ($20.9 Mil) to Jun. 2025 ($22.6 Mil).

Pro Medicus  (OTCPK:PMDIY) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Pro Medicus Marketable Securities Related Terms

Pro Medicus Marketable Securities Historical Data

* Premium members only.

The historical data trend for Pro Medicus's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pro Medicus Marketable Securities Chart

Pro Medicus Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15.12 18.90 20.30 20.92 22.56

Pro Medicus Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.93 20.92 62.94 22.56 69.95
PMDIY
77GF Score
Pro Medicus Ltd PMDIY
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pro Medicus Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of $69.9 Mil mean?
Pro Medicus (PMDIY) has a Marketable Securities of $69.9 Mil as of Dec. 2025. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Pro Medicus and its competitors.
Is Pro Medicus' Marketable Securities too high?
Pro Medicus' current Marketable Securities is $69.9 Mil. Overall, Pro Medicus has a GF Score™ of 77/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Pro Medicus' Marketable Securities compare to VEEV and BTSG?
Pro Medicus' Marketable Securities of $69.9 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Healthcare Providers & Services company?
A good Marketable Securities depends on the Healthcare Providers & Services industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Pro Medicus and its competitors. Pro Medicus's current Marketable Securities is $69.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pro Medicus stock overvalued right now?
Based on GuruFocus' analysis, Pro Medicus (PMDIY) is currently considered Modestly Undervalued. The stock's GF Value™ is $39.90, compared to a current price of $30.00 — trading 24.8% below its estimated fair value. The current Marketable Securities is $69.9 Mil. Pro Medicus' overall GF Score™ is 77/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Pro Medicus (PMDIY), the current Marketable Securities is $69.9 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pro Medicus (PMDIY) Overvalued in 2026?

Based on GuruFocus' analysis, Pro Medicus stock appears to be undervalued. The current stock price of $30.00 is trading 24.8% below its estimated GF Value™ of $39.90. GuruFocus considers Pro Medicus to be Modestly Undervalued.

Key valuation signals for PMDIY:

  • Marketable Securities: $69.9 Mil
  • GF Value™: $39.90 vs. price of $30.00 (24.8% below fair value)
  • GF Score™: 77/100 with 1 warning sign

No single metric tells the full story. See the PMDIY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Pro Medicus Business Description

Address 450 Swan Street, Richmond, VIC, AUS, 3121
Pro Medicus is a healthcare IT company specializing in radiology imaging software. Its main product, Visage 7, is a clinical desktop application that radiologists use to view, enhance, and manipulate images from any device and make a diagnosis. Its main customers are US private academic hospitals. In fiscal 2025, Pro Medicus earned 90% of revenue in North America, 8% from Australia, and the remaining 2% in Europe.
77GF Score

Get the complete analysis for PMDIY

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$30.00
Price
$39.90
GF Value